Octaplex (human prothrombin complex concentrate) / Pfizer, Octapharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octaplex (human prothrombin complex concentrate) / Octapharma, Pfizer
NCT00618098: Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Completed
3
200
US
Octaplex (human prothrombin complex concentrate), Fresh frozen plasma, FFP
Octapharma
Reversal of Anticoagulant Treatment
03/12
08/12
NCT02740335 / 2016-002649-41: Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Completed
3
208
Europe, US, RoW
Octaplex, 4F PCC, 4 Factor PCC, 4 Factor Prothrombin Concentrate Complex, Beriplex P/N (Kcentra), Kcentra
Octapharma
Significant Bleeding Risk
02/22
02/22
LEX-210, NCT04867837 / 2021-000740-21: Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Recruiting
3
260
Europe, US, RoW
Octaplex
Octapharma, Octapharma AG
Acute Major Bleeding
12/24
12/24
FARES-2, NCT05523297: Active-control Randomised Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery

Recruiting
3
500
Canada, US
Octaplex, Frozen Plasma Product, Human
Octapharma
Bleeding Cardiac Surgery Patients
08/24
08/24

Download Options